ResearcherWashington University in St. LouisNo recent work listed
Michael Charles Roach
Matched on ORCID iD 0000-0001-6954-3730; OpenAlex author ID A5051570421. Sources: ClinicalTrials.gov.
Their work
- Papers
- 3
- Trials
- 1 (principal investigator on 1)
- Grants
- 0
- Labs led
- 0
- Collaborators
- 20
2017: 1 trial · 2018: none · 2019: 1 paper · 2020: none · 2021: 1 paper · 2022: none · 2023: 1 paper
Papers 3
- MR-Guided Radiation Therapy With Concurrent Gemcitabine/Nab-Paclitaxel Chemotherapy in Inoperable Pancreatic Cancer: A TITE-CRM Phase I Trial. Co-author DOI 10.1016/j.ijrobp.2022.07.015↗
- Ablative Five-Fraction Stereotactic Body Radiation Therapy for Inoperable Pancreatic Cancer Using Online MR-Guided Adaptation. Co-author DOI 10.1016/j.adro.2020.06.010↗
- Using adaptive magnetic resonance image-guided radiation therapy for treatment of inoperable pancreatic cancer. Co-author DOI 10.1002/cam4.2100↗
Trials 1
Closest collaborators
The 20 strongest of 20 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- William G. Hawkins · 2 shared papers, 2021–2023 · strength 0.26
- Paper MR-Guided Radiation Therapy With Concurrent Gemcitabine/Nab-Paclitaxel Chemotherapy in Inoperable Pancreatic Cancer: A … DOI 10.1016/j.ijrobp.2022.07.015↗
- Paper Ablative Five-Fraction Stereotactic Body Radiation Therapy for Inoperable Pancreatic Cancer Using Online MR-Guided Adap… DOI 10.1016/j.adro.2020.06.010↗
- Hyun Jee Kim · 2 shared papers, 2021–2023 · strength 0.26
- Paper MR-Guided Radiation Therapy With Concurrent Gemcitabine/Nab-Paclitaxel Chemotherapy in Inoperable Pancreatic Cancer: A … DOI 10.1016/j.ijrobp.2022.07.015↗
- Paper Ablative Five-Fraction Stereotactic Body Radiation Therapy for Inoperable Pancreatic Cancer Using Online MR-Guided Adap… DOI 10.1016/j.adro.2020.06.010↗
- Lauren E. Henke · 2 shared papers, 2021–2023 · strength 0.26
- Paper MR-Guided Radiation Therapy With Concurrent Gemcitabine/Nab-Paclitaxel Chemotherapy in Inoperable Pancreatic Cancer: A … DOI 10.1016/j.ijrobp.2022.07.015↗
- Paper Ablative Five-Fraction Stereotactic Body Radiation Therapy for Inoperable Pancreatic Cancer Using Online MR-Guided Adap… DOI 10.1016/j.adro.2020.06.010↗
- Ryan C Fields · 2 shared papers, 2021–2023 · strength 0.26
- Paper MR-Guided Radiation Therapy With Concurrent Gemcitabine/Nab-Paclitaxel Chemotherapy in Inoperable Pancreatic Cancer: A … DOI 10.1016/j.ijrobp.2022.07.015↗
- Paper Ablative Five-Fraction Stereotactic Body Radiation Therapy for Inoperable Pancreatic Cancer Using Online MR-Guided Adap… DOI 10.1016/j.adro.2020.06.010↗
- Andrea Wang‐Gillam · 2 shared papers, 2021–2023 · strength 0.26
- Paper MR-Guided Radiation Therapy With Concurrent Gemcitabine/Nab-Paclitaxel Chemotherapy in Inoperable Pancreatic Cancer: A … DOI 10.1016/j.ijrobp.2022.07.015↗
- Paper Ablative Five-Fraction Stereotactic Body Radiation Therapy for Inoperable Pancreatic Cancer Using Online MR-Guided Adap… DOI 10.1016/j.adro.2020.06.010↗
- Parag Jitendra Parikh · 2 shared papers, 2019–2023 · strength 0.22
- Paper MR-Guided Radiation Therapy With Concurrent Gemcitabine/Nab-Paclitaxel Chemotherapy in Inoperable Pancreatic Cancer: A … DOI 10.1016/j.ijrobp.2022.07.015↗
- Paper Using adaptive magnetic resonance image-guided radiation therapy for treatment of inoperable pancreatic cancer. DOI 10.1002/cam4.2100↗
- Soumon F. Rudra · 2 shared papers, 2019–2021 · strength 0.20
- Benjamin R. Tan · 1 shared paper, 2023 · strength 0.14
- Katrina Sophia Pedersen · 1 shared paper, 2023 · strength 0.14
- Todd A. DeWees · 1 shared paper, 2023 · strength 0.14
- Kian‐Huat Lim · 1 shared paper, 2023 · strength 0.14
- Shahed Nicolas Badiyan · 1 shared paper, 2023 · strength 0.14
- Chet W. Hammill · 1 shared paper, 2023 · strength 0.14
- Comron Hassanzadeh · 1 shared paper, 2021 · strength 0.12
- Michael Frederick Bassetti · 1 shared paper, 2019 · strength 0.08
- Eric A. Mellon · 1 shared paper, 2019 · strength 0.08
- Anna M E Bruynzeel · 1 shared paper, 2019 · strength 0.08
- Frank J. Lagerwaard · 1 shared paper, 2019 · strength 0.08
- Lorraine Portelance · 1 shared paper, 2019 · strength 0.08
- Percy P. Lee · 1 shared paper, 2019 · strength 0.08
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.